Chris Dobson

Dobson in 2014 Sir Christopher Martin Dobson (8 October 1949 – 8 September 2019) was a British chemist, who was the John Humphrey Plummer Professor of Chemical and Structural Biology in the Department of Chemistry at the University of Cambridge, and Master of St John's College, Cambridge. Provided by Wikipedia
Showing 1 - 13 results of 13 for search 'Christopher M. Dobson', query time: 0.89s Refine Results
  1. 1
    A simple lattice model that captures protein folding, aggregation and amyloid formation.

    A simple lattice model that captures protein folding, aggregation and amyloid formation. by Sanne Abeln, Michele Vendruscolo, Christopher M Dobson, Daan Frenkel

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila.

    The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila. by Jenna M Gregory, Teresa P Barros, Sarah Meehan, Christopher M Dobson, Leila M Luheshi

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Basosquamous Carcinoma: A Single Centre Clinicopathological Evaluation and Proposal of an Evidence-Based Protocol

    Basosquamous Carcinoma: A Single Centre Clinicopathological Evaluation and Proposal of an Evidence-Based Protocol by Jordan W. Oldbury, Richard A. J. Wain, Sameera Abas, Christopher M. Dobson, Srinivasan S. Iyer

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Inversion of the balance between hydrophobic and hydrogen bonding interactions in protein folding and aggregation.

    Inversion of the balance between hydrophobic and hydrogen bonding interactions in protein folding and aggregation. by Anthony W Fitzpatrick, Tuomas P J Knowles, Christopher A Waudby, Michele Vendruscolo, Christopher M Dobson

    Published 2011-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ.

    Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ. by David C Butler, Shubhada N Joshi, Erwin De Genst, Ankit S Baghel, Christopher M Dobson, Anne Messer

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    In-cell NMR characterization of the secondary structure populations of a disordered conformation of α-synuclein within E. coli cells.

    In-cell NMR characterization of the secondary structure populations of a disordered conformation of α-synuclein within E. coli cells. by Christopher A Waudby, Carlo Camilloni, Anthony W P Fitzpatrick, Lisa D Cabrita, Christopher M Dobson, Michele Vendruscolo, John Christodoulou

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Analysis of the native structure, stability and aggregation of biotinylated human lysozyme.

    Analysis of the native structure, stability and aggregation of biotinylated human lysozyme. by Minkoo Ahn, Erwin De Genst, Gabriele S Kaminski Schierle, Miklos Erdelyi, Clemens F Kaminski, Christopher M Dobson, Janet R Kumita

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Native-state stability determines the extent of degradation relative to secretion of protein variants from Pichia pastoris.

    Native-state stability determines the extent of degradation relative to secretion of protein variants from Pichia pastoris. by Graham Whyteside, Marcos J C Alcocer, Janet R Kumita, Christopher M Dobson, Maria Lazarou, Richard J Pleass, David B Archer

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity.

    Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. by Leila M Luheshi, Gian Gaetano Tartaglia, Ann-Christin Brorsson, Amol P Pawar, Ian E Watson, Fabrizio Chiti, Michele Vendruscolo, David A Lomas, Christopher M Dobson, Damian C Crowther

    Published 2007-10-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation.

    Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation. by Cintia Roodveldt, Adahir Labrador-Garrido, Elena Gonzalez-Rey, Christian C Lachaud, Tim Guilliams, Rafael Fernandez-Montesinos, Alicia Benitez-Rondan, Gema Robledo, Abdelkrim Hmadcha, Mario Delgado, Christopher M Dobson, David Pozo

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.

    Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo. by Leila M Luheshi, Wolfgang Hoyer, Teresa Pereira de Barros, Iris van Dijk Härd, Ann-Christin Brorsson, Bertil Macao, Cecilia Persson, Damian C Crowther, David A Lomas, Stefan Ståhl, Christopher M Dobson, Torleif Härd

    Published 2010-03-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate.

    Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. by Kiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, Vaibhav Srivastava, Andrei Shchukarev, Ann-Christin Brorsson, Gian Gaetano Tartaglia, Thomas Vogl, Rakez Kayed, Gunnar Wingsle, Jan Olsson, Christopher M Dobson, Anders Bergh, Fredrik Elgh, Ludmilla A Morozova-Roche

    Published 2009-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

    Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. by Gergely Tóth, Shyra J Gardai, Wagner Zago, Carlos W Bertoncini, Nunilo Cremades, Susan L Roy, Mitali A Tambe, Jean-Christophe Rochet, Celine Galvagnion, Gaia Skibinski, Steven Finkbeiner, Michael Bova, Karin Regnstrom, San-San Chiou, Jennifer Johnston, Kari Callaway, John P Anderson, Michael F Jobling, Alexander K Buell, Ted A Yednock, Tuomas P J Knowles, Michele Vendruscolo, John Christodoulou, Christopher M Dobson, Dale Schenk, Lisa McConlogue

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: